Saturday 7 November 2026 Export PHAT’s income statement to Excel — free account

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $175.1 million, up 216.9% from fiscal 2024.

Revenue: +71.1%
EPS: +60.1%
Free cash flow: +112.2%
Total debt: −20.1%

Quarter to September 2026, against a year earlier

5.23 0.15 +2.95%

Follow PHAT

Alert me

Market cap: $413.0M
P/E: 0.0×
Fwd P/E: −7.5×
Dividend yield: —
F-score: 4/9
Altman Z: −7.89
Beneish M: −1.39
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	63.97%	46.58%	26.42%	21.55%
ROA Full definition →		(69.41%)	(52.49%)	(34.32%)	(28.36%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(225.78%)	(103.12%)	(69.23%)	(61.92%)
Average Days of Receivables Full definition →		162.85	143.80	148.37	142.88
Free Cash Flow per Share Full definition →		(2.29)	(1.19)	(0.44)	(0.25)
Free Cash Flow Full definition →		(167.00)	(97.76)	(36.91)	(21.04)
Capital Expenditures Full definition →		(0.23)	(0.27)	(0.22)	(0.30)
Other line items
Cash ROIC Full definition →		168.50%	(1,282.32%)	(1,322.06%)	(855.67%)
Accounts Receivable Turnover Full definition →		3.00	3.50	3.22	3.36
Accounts Payable Turnover Full definition →		2.92	3.43	8.74	8.72
Inventory Turnover Full definition →		5.18	6.38	7.35	9.45
Average Days of Payables Full definition →		80.48	75.26	47.81	76.35
Days of Inventory on Hand Full definition →		89.12	76.95	68.78	52.46
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		18.72%	15.31%	12.56%	11.58%
Selling, General and Administrative Expense of Revenue Full definition →		159.74%	116.77%	87.32%	78.36%
Share Based Compensation of Revenue Full definition →		16.40%	14.01%	11.33%	8.65%
Interest Coverage Full definition →		(2.35)	(1.47)	(0.64)	(0.41)
Operating CF/Net income Full definition →		0.75	0.62	0.37	0.25
Depreciation/Fixed assets Full definition →		3.43	3.67	3.96	4.27
Capex/Depreciation Full definition →		(0.06)	(0.07)	(0.06)	(0.08)
Revenue per Share Full definition →		2.40	2.50	2.86	3.24
Operating CF per Share Full definition →		(2.29)	(1.19)	(0.44)	(0.24)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly